Yuko Ito

1.3k total citations
63 papers, 1.0k citations indexed

About

Yuko Ito is a scholar working on Molecular Biology, Pharmacology and Spectroscopy. According to data from OpenAlex, Yuko Ito has authored 63 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Molecular Biology, 16 papers in Pharmacology and 16 papers in Spectroscopy. Recurrent topics in Yuko Ito's work include Pharmacogenetics and Drug Metabolism (16 papers), Computational Drug Discovery Methods (11 papers) and ATP Synthase and ATPases Research (10 papers). Yuko Ito is often cited by papers focused on Pharmacogenetics and Drug Metabolism (16 papers), Computational Drug Discovery Methods (11 papers) and ATP Synthase and ATPases Research (10 papers). Yuko Ito collaborates with scholars based in Japan, United Kingdom and United States. Yuko Ito's co-authors include David F. Lewis, Mitsunori Ikeguchi, Brian G. Lake, Peter S. Goldfarb, Takashi Hirano, Masahiro Kinoshita, Takashi Yoshidome, Fumiya Mito, Toshihide Yamasaki and Ken‐ichi Yamada and has published in prestigious journals such as Journal of the American Chemical Society, The Journal of Chemical Physics and The Journal of Physical Chemistry B.

In The Last Decade

Yuko Ito

59 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yuko Ito Japan 20 492 191 148 121 119 63 1.0k
Michael A. Noble United Kingdom 16 597 1.2× 466 2.4× 83 0.6× 34 0.3× 67 0.6× 22 1.1k
Brian Y. Feng United States 11 1.2k 2.5× 95 0.5× 114 0.8× 48 0.4× 157 1.3× 18 1.9k
Thompson N. Doman United States 12 831 1.7× 86 0.5× 108 0.7× 31 0.3× 153 1.3× 24 1.5k
Gloria L. Silva Argentina 19 821 1.7× 78 0.4× 108 0.7× 84 0.7× 228 1.9× 29 1.4k
E. Obayashi Japan 20 759 1.5× 213 1.1× 68 0.5× 39 0.3× 88 0.7× 31 1.4k
Sundarapandian Thangapandian South Korea 20 771 1.6× 76 0.4× 41 0.3× 43 0.4× 59 0.5× 44 1.2k
Kunqian Yu China 23 844 1.7× 62 0.3× 132 0.9× 15 0.1× 197 1.7× 56 1.4k
Carlos G. Acevedo‐Rocha Germany 27 2.0k 4.0× 314 1.6× 109 0.7× 30 0.2× 186 1.6× 51 2.4k
Grégori Gerebtzoff Switzerland 11 460 0.9× 84 0.4× 127 0.9× 12 0.1× 109 0.9× 16 1.1k
Yuanchao Zhang China 16 632 1.3× 95 0.5× 40 0.3× 17 0.1× 166 1.4× 29 1.1k

Countries citing papers authored by Yuko Ito

Since Specialization
Citations

This map shows the geographic impact of Yuko Ito's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuko Ito with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuko Ito more than expected).

Fields of papers citing papers by Yuko Ito

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuko Ito. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuko Ito. The network helps show where Yuko Ito may publish in the future.

Co-authorship network of co-authors of Yuko Ito

This figure shows the co-authorship network connecting the top 25 collaborators of Yuko Ito. A scholar is included among the top collaborators of Yuko Ito based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuko Ito. Yuko Ito is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Otsuka, Yuichiro, Tetsuya Maeda, Jun Ishii, et al.. (2024). Prognostic and diagnostic effects of high serum midkine levels in patients with hepatocellular carcinoma. Oncology Letters. 27(6). 283–283. 2 indexed citations
2.
3.
Ito, Yuko, et al.. (2017). Dissection of the angle of single fluorophore attached to the nucleotide in corkscrewing microtubules. Biochemical and Biophysical Research Communications. 485(3). 614–620. 8 indexed citations
5.
Ito, Yuko & Mitsunori Ikeguchi. (2015). Mechanism of the αβ Conformational Change in F1-ATPase after ATP Hydrolysis: Free-Energy Simulations. Biophysical Journal. 108(1). 85–97. 18 indexed citations
6.
Ito, Yuko & Mitsunori Ikeguchi. (2013). Molecular Dynamics Simulations of F1-ATPase. Advances in experimental medicine and biology. 805. 411–440. 5 indexed citations
7.
Mito, Fumiya, Toshihide Yamasaki, Yuko Ito, et al.. (2011). Monitoring the aggregation processes of amyloid-β using a spin-labeled, fluorescent nitroxyl radical. Chemical Communications. 47(17). 5070–5070. 7 indexed citations
8.
Mito, Fumiya, Kana Kitagawa, Toshihide Yamasaki, et al.. (2011). Oxygen concentration dependence of lipid peroxidation and lipid-derived radical generation: Application of profluorescent nitroxide switch. Free Radical Research. 45(9). 1103–1110. 11 indexed citations
9.
Lewis, David F., Yuko Ito, & Brian G. Lake. (2009). Electronic and Structural Aspects of P450-Mediated Drug Metabolism. Drug Metabolism Letters. 3(2). 87–100. 2 indexed citations
10.
Lewis, David F. & Yuko Ito. (2008). Human cytochromes P450 in the metabolism of drugs: new molecular models of enzyme–substrate interactions. Expert Opinion on Drug Metabolism & Toxicology. 4(9). 1181–1186. 28 indexed citations
11.
Lewis, David F., Brian G. Lake, Yuko Ito, & Pavel Anzenbacher. (2006). QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIPS (QSARs) WITHIN CYTOCHROMES P450 2B (CYP2B) SUBFAMILY ENZYMES: THE IMPORTANCE OF LIPOPHILICITY FOR BINDING AND METABOLISM. Drug metabolism and drug interactions. 21(3-4). 213–232. 5 indexed citations
12.
Lewis, D. F. V., Yuko Ito, & Peter S. Goldfarb. (2006). Investigating Human P450s Involved in Drug Metabolism via Homology with High-Resolution P450 Crystal Structures of the CYP2C Subfamily. Current Drug Metabolism. 7(6). 589–598. 9 indexed citations
13.
Lewis, D. F. V., Yuko Ito, & Peter S. Goldfarb. (2006). Structural Modelling of the Human Drug-Metabolizing Cytochromes P450. Current Medicinal Chemistry. 13(22). 2645–2652. 14 indexed citations
14.
Lewis, David F., Brian G. Lake, Yuko Ito, & Maurice Dickins. (2006). Lipophilicity Relationships in Inhibitors of CYP2C9 and CYP2C19 Enzymes. Journal of Enzyme Inhibition and Medicinal Chemistry. 21(4). 385–389. 17 indexed citations
15.
Lewis, David F., Yuko Ito, & Brian G. Lake. (2005). Metabolism of coumarin by human P450s: A molecular modelling study. Toxicology in Vitro. 20(2). 256–264. 39 indexed citations
16.
Ito, Yuko, et al.. (2004). Stability of non-Watson-Crick G-A/A-G base pair in synthetic DNA and RNA oligonucleotides. Molecular Biology Reports. 31(1). 31–36. 5 indexed citations
17.
Ito, Yuko & Takashi Hirano. (1999). A Group I Intron in the 18S Ribosomal DNA from the Parasitic Fungus Isaria japonica. Journal of Molecular Evolution. 48(3). 337–340. 5 indexed citations
18.
Kondo, Tadashi, Hiroaki Terajima, Takeshi Todoroki, et al.. (1999). Prevention of Hepatic Ischemia–Reperfusion Injury by SOD–DIVEMA Conjugate. Journal of Surgical Research. 85(1). 26–36. 21 indexed citations
19.
Ishida, Hideharu, et al.. (1997). Synthesis of 6′-GM2, a regioisomer of ganglioside GM2, for studying the mechanism of action of GM2 activator. Carbohydrate Research. 302(3-4). 223–227. 8 indexed citations
20.
Kato, Tetsuya, et al.. (1990). Microbial contamination of stock solution for soft contact lens. 44(7). 1037–1040. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026